Recent Updates

Modified on: 
May 23, 2018
Share
Twitter Facebook LinkedIn Forward

Use of cytomegalovirus (CMV) seronegative blood products

Current recommendations of the NAC indicate that the provision of CMV-seronegative and leukoreduced blood products is potentially required only in the setting of intrauterine transfusion. In October 2017, Canadian Blood Services will stop the testing donor blood for anti-CMV antibodies except for a small inventory of blood components tested for the sole purpose of intrauterine transfusion.

Transfusion
Share
Twitter Facebook LinkedIn Forward
Published: 
Aug 2, 2017

Neonatal and Pediatric Transfusion

Chapter 13

While the practice of transfusion of blood products to neonatal and pediatric recipients has much in common with the transfusion of blood products to adults, there are several important differences and special circumstances. This chapter highlights the most common considerations that are unique to this group of patients.

Transfusion
Share
Twitter Facebook LinkedIn Forward
Published: 
Aug 4, 2017

CMV Seronegative, Irradiated and Washed Blood Components

Chapter 15

Modified or specialty blood components may be useful in specific clinical settings to reduce the risk of transfusion-related harm. Specialty blood products available to physicians include CMV-seronegative, irradiated, and washed red blood cells or platelets. This chapter describes the preparation of these blood components and the clinical setting in which they are of greatest benefit.

Transfusion
more

Upcoming Events

(Re) imagining Health: Sickle Cell Anemia & Thalassaemia: An International Biomedical-Sociocultural Conference

Share
Twitter Facebook LinkedIn Forward
When
November 16, 2018 | 8:00AM to November 17, 2018 | 6:00PM
Where

Edmonton

The purpose of the conference is to bring together multiple voices to support and build inclusive an equitable teaching and learning environments for medical staff, sickle cell disease patients, their families, first responders the public and other stakeholders. The event will be targeted towards physicians, surgeons, researchers and other medical practitioners within the community committed to finding a cure for Sickle Cell Anemia and more knowledge of the continued effects of sickle cell anemia trait.

Transfusion
Stem Cells

35th International congress of the ISBT

Share
Twitter Facebook LinkedIn Forward
When
June 2, 2018 | 8:00AM to June 7, 2018 | 5:00PM
Where

Toronto

Check out the CSTM website and the ISBT website  for more information.

Transfusion
Stem Cells

CSTM Local Day at the 35th International congress of the ISBT

Share
Twitter Facebook LinkedIn Forward
When
June 2, 2018 | 8:00AM to 5:30PM
Where

Toronto

Check out the ISBT website for more information on Local Day hosted by CSTM. 

Transfusion
Stem Cells
more

Blog

Kidney graphic

Modified on: 
May 23, 2018
Share
Twitter Facebook LinkedIn Forward

Dr. Peter Nickerson awarded Kidney Foundation Medal for Research Excellence

On May 5th, the Kidney Foundation of Canada announced that Dr. Peter Nickerson is the winner of their 2018 Medal for Research Excellence. A well deserved honour indeed. We're proud to congratulate Dr. Nickerson on this award. 

Norman Bethune Symposium 2018

Modified on: 
May 17, 2018
Share
Twitter Facebook LinkedIn Forward

Looking back to look forward: Bethune’s legacy of innovation celebrated at the 2018 Norman Bethune Symposium

On April 10th, 2018, the Centre for Blood Research presented its 8th Annual Norman Bethune Symposium. This event honours Canadian physician, Dr. Norman Bethune, who in the 1930s spearheaded the implementation of the earliest practical mobile blood collection and distribution systems. 

lifetime achievement award

Modified on: 
May 9, 2018
Share
Twitter Facebook LinkedIn Forward

James Kreppner Award goes to University of Saskatchewan’s Alana Cattapan

Alana Cattapan, assistant professor in the Johnson Shoyama Graduate School of Public Policy (JSGS) at the University of Saskatchewan (U of S) has been awarded the Canadian Blood Services’ James Kreppner Award ($43,275) to study the issues related to the commercialization of blood and tissue in Canada. 

more